RecruitingPhase 3NCT07177339
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Sponsor: GlaxoSmithKline
Dallas, TX · DeSoto, TX · Greenville, TX · +39 more sites